Lab scale product development as well as supportive studies required for the development

End to end product development and regulatory support for humic substance based products

In vivo and in vitro required as per regulatory requirement

Examination of sampled tissues (in the form of slides) under the microscope and interpretation according to pathogenesis or treatment.

Health Based exposure limit is a scientifically based safe threshold level for an active substances. Manufacturing of active pharmaceutical ingredients.

Impurity/intermediate synthesis and their characterizations using different spectroscopic (UV-Visible spectrophotometer, FT-IR, NMR) and integrated chromatographic techniques (HPLC and UPLC-MS/MS).

Development of novel solid forms of API e.g. Polymorphs, solvates, cocrystals, co amorphous,eutectic mixtures etc. Particle engineering for better biopharmaceutical properties.

Database and literature searches provide a situation review and analysis in the form of structured reports on the evidence available with respect to various health economics and outcomes aspects such as epidemiology.